Dr Nijjer performs coronary intervention at the catheter suites of both the Hammersmith Hospital and Chelsea & Westminster NHS Foundation Trust.  He is part of the Primary Angioplasty on-call service at the Hammersmith Hospital.  He is an established leader in invasive coronary physiology which can help guide Cardiologists on when and where a coronary stent is needed.  He is regularly invited as a speaker at international conferences including the American College of Cardiology and TCT.

Dr. Nijjer studied medicine at the University of Bristol, where he graduated with Honours in 2004 with two undergraduate scholarships and many academic prizes. He was also awarded a First Class Honours degree with prizes in Pharmacology which was supported by the prestigious Wolfson Award from the Royal College of Physicians. He undertook his Junior Doctor training at the Hammersmith Hospital and Royal Brompton Hospital before being appointed as a Specialist Registrar in Cardiology in 2008. He is undertook rigorous training in all aspects of Cardiology and completed a 2 year fellowship in Interventional Cardiology at the Hammersmith Hospital.

Dr. Nijjer is committed to the better treatment of patients through the development and application of new medical technologies.  His PhD, funded by the Medical Research Council and awarded by Imperial College, involved the development of new techniques (iFR and iFR-pullback) to measure blood flow in coronary arteries with blockages.  Dr Nijjer pioneered the use of iFR-pullback to better treat coronary blockages and this technology has been used in thousands of patients around the world. 

All aspects of cardiology:

• Chest pain
• Angina
• Patients at risk of heart disease such as patients with high blood pressure, diabetes or raised cholesterol
• Breathlessness on exertion, alpitations or collapse

• Member of the Royal College of Physicians
• British Cardiac Society
• British Cardiac Intervention Society
• European Society of Cardiology Microcirculation Working Group
• European Association of Percutaneous Cardiovascular Interventions